PRAX — Praxis Precision Medicines Share News
0.000.00%
Last trade - 00:00Brief: Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Praxis Precision Medicines, Inc. reports results for the quarter ended June 30 - Earnings Summary
Praxis Precision Q2 net loss widens on higher expenses
Brief: Praxis Precision Q2 EPS USD -2.87
Praxis Precision Medicines Inc expected to post a loss of $3.66 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Hewlett Packard, Alphabet, Fulcrum
U.S. STOCKS ON THE MOVE-Hewlett Packard, Alphabet, Philip Morris
U.S. STOCKS ON THE MOVE-Dollar General, Vera, Amtech Systems
Praxis falls after epilepsy drug setback in study
U.S. RESEARCH ROUNDUP-Edgewise Therapeutics, IBM, Rubrik
Praxis falls after epilepsy drug misses main goal in mid-to-late stage study
Praxis Precision's epilepsy drug misses main goal of mid-to-late stage study
NASDAQ RESUMED AT 04:45 PM
NASDAQ TRADE HALT HALT NEWS PENDING AT 04:10 PM
U.S. RESEARCH ROUNDUP-Aecom, Humana, Mosaic
Praxis Precision's Q1 net loss widens on higher expenses
Brief: Praxis Precision Q1 EPS USD -3.2
Praxis rises as FDA sets review date for drug to treat essential tremor
U.S. STOCKS ON THE MOVE-Tesla, Norfolk Southern, Denali